Topic number
1 . 2021
Evolution of pharmacotherapy for diabetes mellitus
Content
Editorial

To the anniversary of Ivan I. Dedov

Abstract

To the anniversary of Mikhail B. Antsiferov

Abstract

Selected lectures from the XVIII World Congress Insulin Resistance «Diabetes & Cardiovascular Disease»

Abstract
COVID-19 made significant changes in the organization of many events, taking into account all the restrictions in 2020, the World Congress on Insulin Resistance «Diabetes & Cardiovascular Disease» was held remotely, but in the welcome video, Congress Chairman

Clinical inertia in preventing cardiovascular mortality and prolonging the life of patients with type 2 diabetes mellitus and cardiovascular diseases

Abstract
The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed to herald a new era in the management of type 2 diabetes mellitus (T2DM), especially for the many patients with T2DM who are at high risk for cardiovascular and renal events. However,
Reviews

Basal insulin evolution: from simple to more complex

Abstract
Insulin therapy is the main component of the type 1 diabetes treatment. Since the discovery of insulin in 1920's and to the present day the improvement of insulin has been an ongoing process. In a century insulin therapy has gone from insulin extracted from cattle pancreas

Insulin therapy is a century-long success story. Focus on basal insulin

Abstract
Insulin was discovered 100 years ago, but interest in the study of this molecule does not Lose its relevance. The review reflects the evolution of basal insulin preparations from the moment of their creation to the present day. Much attention is paid to the fundamental

Clinical cases: hyperprolactinemia in men and women of different age. Whom, how and how long to treat?

Abstract
The review article provides data on the prevalence, causes, and approaches to the diagnosis and treatment of hyperprolactinemia. Hyperprolactinemia is a common endocrine pathology that can occur in men and women of different age periods. There are physiological and

Risk factors for thyroid oncogenesis. Contribution of genetic mutations, oncogenes, diselementosis and growth factors to the formation of follicular neoplasms of the thyroid gland in persons with visceral obesity

Abstract
The problem of the growth of benign and malignant tumors of the thyroid gland (TG) in recent years has become especially acute. In the structure of all neoplasms of the endocrine system, they account for 90%. Due to the availability of ultrasound examination, nodular

Vascular aging and type 2 diabetes mellitus

Abstract
Cardiovascular diseases remain the leading cause of morbidity and mortality in developed countries, and chronological age, along with others, is the main risk factor for their development. Current strategies for increasing life expectancy and improving health require
To practitioner`s consult

Experience of using the russian dipeptidyl peptidase-4 inhibitor gosogliptin. Results of the ONYX study

Abstract
The choice of tactics for the treatment of type 2 diabetes mellitus is personalized, based on the clinical condition of the patient. Of the 9 classes of antidiabetic drugs used, dipeptidyl peptidase-4 (iDPP-4) inhibitors have become firmly established in medical practice
То practitioner’s consult. Time in range

Dear collugues!

Abstract

Continuous flash glycemic monitoring in optimizing insulin pump therapy in a patient with type 1 diabetes mellitus: clinical case

Abstract
Many patients with type 1 diabetes mellitus (T1DM) undergoing pump insulin therapy have insufficient glycemic control and, as a result, inappropriate indicators of carbohydrate metabolism. This clinical case shows us the clinical experience of pump insulin therapy
Clinical cases

The dynamics of carbohydrate metabolism associated with COVID-19 (role and place of Flash-glucose monitoring)

Abstract
These clinical cases show the reflection of the COVID-impact on the expression of different disturbance of carbohydrate metabolism, registrated using Flash glucose monitoring (hypo-, hyperglycemia, dynamics of glycemic variability). The first case presented the manifestation

Еxperience of using selective blood sampling from the adrenal veins in a patient with primary hyperaldosteronism: a clinical case

Abstract
Primary hyperaldosteronism is one of the most common causes of secondary hypertension. In this disease, the source of increased aldosterone levels is tumor or hyperplastic changes in the glomerular zone of the adrenal cortex. The development of primary hyperaldosteronism can
Continuing medical education

Features of admission to the professional activity of an endocrinologist in 2021-2025

Abstract
Continuing medical education of a doctor is associated with admission to professional activity through certification or accreditation. The Ministry of Health of Russia intends in 2021 to approve a new Regulation on the accreditation of specialists to replace the one approved
News

News (# 1, 2021)

Abstract
Information

Congress dedicated to World Obesity Day

Abstract

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»